"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study

M Vervloet, V Bencova, F Malberti, N Ashman, I Os, H Saha, P Ureña, E Zitt, M Rix, M Ryba, D Fouque, B Dehmel, F Petavy, Stephen Jacobson

    16 Citationer (Scopus)

    Abstract

    The pan-European ECHO observational study evaluated cinacalcet in adult dialysis patients with secondary hyperparathyroidism (SHPT) in "real-world" clinical practice. A sub-analysis compared data for 7 European countries/country clusters: Austria, CEE (Czech Republic and Slovakia), France, Italy, Netherlands, Nordics (Denmark, Finland, Norway, and Sweden), and the UK/Ireland.
    OriginalsprogEngelsk
    TidsskriftClinical Nephrology
    Vol/bind74
    Udgave nummer3
    Sider (fra-til)198-208
    Antal sider11
    ISSN0301-0430
    StatusUdgivet - 1 sep. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om '"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study'. Sammen danner de et unikt fingeraftryk.

    Citationsformater